In addition, CD40L, which is predominantly expressed on activated CD4+ T cells, has been reported to activate both the canonical and noncanonical pathway in human CLL cells, in contrast to murine B-cells where it selectively activates the noncanonical pathway [27, 28]. Here, CD4 is linked to B-cell chronic lymphocytic leukemia.